Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences

Statistics in Medicine
S D WalterP Macaskill

Abstract

Outcomes in a clinical trial can be affected by any underlying preferences that its participants have for the treatments under comparison and by whether they actually receive their preferred treatment. These effects cannot be evaluated in standard trial designs but are estimable in the alternative two-stage randomised trial design, in which some patients can choose their treatment, while the rest are randomly assigned. We have previously shown that, when all two-stage trial participants have a preferred treatment, the preference effects can be evaluated, in addition to the usual direct effect of treatment. We also determined criteria by which to optimise how many participants should be given a choice of treatment vs being randomised. More recently, we extended our methodology to allow for participants who are unable or unwilling to express a treatment preference if they are assigned to the choice group. In this paper, we show how to optimise the two-stage design when some participants are undecided about their treatment. We demonstrate that the undecided group should be regarded as distinct in the analysis, to obtain valid estimates of the preference effects. We derive the optimal proportion of participants who should be offere...Continue Reading

References

May 31, 1979·The New England Journal of Medicine·M Zelen
Jun 1, 1990·Statistics in Medicine·M Zelen
Aug 27, 1982·JAMA : the Journal of the American Medical Association·B R CassilethS Hurwitz
Mar 22, 2002·Journal of Internal Medicine·S M MadsenP Riis
Jan 8, 2005·BMJ : British Medical Journal·P J DevereauxGordon H Guyatt
Mar 3, 2005·JAMA : the Journal of the American Medical Association·Michael KingRosalind Lai
Aug 19, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L E BurkeS M Sereika
Sep 22, 2007·Journal of Clinical Epidemiology·Debra FayterAlison Eastwood
Oct 7, 2008·Statistics in Medicine·S D WalterUNKNOWN SPRINT Study Investigators
Jun 24, 2010·Journal of Empirical Research on Human Research Ethics : JERHRE·Anna H L Floyd, Anne Moyer
Nov 3, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Kirsten J McCafferyLes Irwig
Jan 29, 2014·The Cochrane Database of Systematic Reviews·Dawn StaceyJulie H C Wu
Apr 4, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Robin M TurnerLes Irwig
Jul 30, 2014·Critical Reviews in Therapeutic Drug Carrier Systems·Indu Pal KaurGaurav Sharma
Sep 13, 2014·Statistical Methods in Medical Research·S D WalterL Irwig
Sep 18, 2015·International Journal of Epidemiology·John O YoungeM G Myriam Hunink
May 10, 2017·Journal of Clinical Epidemiology·Juan Jose Yepes-NuñezGordon Guyatt

❮ Previous
Next ❯

Citations

Jul 25, 2020·Statistical Methods in Medical Research·S D Walter, M Bian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.